vs
AURORA CANNABIS INC（ACB）与MediWound Ltd.（MDWD）财务数据对比。点击上方公司名可切换其他公司
MediWound Ltd.的季度营收约是AURORA CANNABIS INC的60.6倍（$5.7M vs $94.2K）。AURORA CANNABIS INC净利率更高（-1.9% vs -233.3%，领先231.5%）
奥罗拉大麻公司是加拿大获得官方许可的大麻生产商，总部位于埃德蒙顿。截至2018年9月，公司拥有八家合规生产工厂、五张销售牌照，业务遍及全球25个国家，年大麻产能超62.5万公斤，核心产能布局在加拿大，同时在丹麦、拉美等国际市场积极拓展业务。
MediWound Ltd.是一家聚焦烧伤护理、慢性创面治疗及软组织修复领域的生物制药企业，研发、生产及销售创新创面护理产品，主要面向北美、欧洲及亚洲市场的医院、医疗机构及患者提供服务。
ACB vs MDWD — 直观对比
营收规模更大
MDWD
是对方的60.6倍
$94.2K
净利率更高
ACB
高出231.5%
-233.3%
损益表 — Q3 2026 vs Q2 2025
| 指标 | | |
|---|---|---|
| 营收 | $94.2K | $5.7M |
| 净利润 | $-1.7K | $-13.3M |
| 毛利率 | — | 23.5% |
| 营业利润率 | — | -100.1% |
| 净利率 | -1.9% | -233.3% |
| 营收同比 | — | 12.7% |
| 净利润同比 | — | -111.2% |
| 每股收益（稀释后） | — | $-1.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACBMDWD
| Q4 25 | $94.2K | — | ||
| Q2 25 | — | $5.7M | ||
| Q1 25 | $90.5K | — | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | $45.6K | — | ||
| Q2 23 | $81.6M | $4.8M | ||
| Q2 22 | — | $4.7M |
净利润ACBMDWD
| Q4 25 | $-1.7K | — | ||
| Q2 25 | — | $-13.3M | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $-6.3M | ||
| Q1 24 | — | — | ||
| Q2 23 | $-617.0M | $916.0K | ||
| Q2 22 | — | $-4.4M |
毛利率ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | 23.5% | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 8.8% | ||
| Q1 24 | 54.0% | — | ||
| Q2 23 | 8.7% | 23.8% | ||
| Q2 22 | — | 23.8% |
营业利润率ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | -100.1% | ||
| Q1 25 | — | — | ||
| Q2 24 | — | -88.6% | ||
| Q1 24 | — | — | ||
| Q2 23 | -73.7% | -84.0% | ||
| Q2 22 | — | -78.7% |
净利率ACBMDWD
| Q4 25 | -1.9% | — | ||
| Q2 25 | — | -233.3% | ||
| Q1 25 | — | — | ||
| Q2 24 | — | -124.5% | ||
| Q1 24 | — | — | ||
| Q2 23 | -756.4% | 19.2% | ||
| Q2 22 | — | -93.3% |
每股收益（稀释后）ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | $-1.23 | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $-0.68 | ||
| Q1 24 | — | — | ||
| Q2 23 | — | $0.10 | ||
| Q2 22 | — | $-0.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $20.1M |
| 总资产 | — | $67.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $3.8M | ||
| Q1 24 | — | — | ||
| Q2 23 | — | $19.2M | ||
| Q2 22 | — | $7.7M |
股东权益ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | $20.1M | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $17.9M | ||
| Q1 24 | — | — | ||
| Q2 23 | — | $34.9M | ||
| Q2 22 | — | $-2.2M |
总资产ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | $67.0M | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $57.3M | ||
| Q1 24 | — | — | ||
| Q2 23 | — | $64.4M | ||
| Q2 22 | — | $21.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | $-5.8M | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $-3.6M | ||
| Q1 24 | — | — | ||
| Q2 23 | $-4.3M | $-5.3M | ||
| Q2 22 | — | $-5.3M |
自由现金流ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | $-8.6M | — | ||
| Q2 22 | — | — |
自由现金流率ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | -10.6% | — | ||
| Q2 22 | — | — |
资本支出强度ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 5.3% | — | ||
| Q2 22 | — | — |
现金转化率ACBMDWD
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | -5.73× | ||
| Q2 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
